How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The case for—and against—digital employees by Mike Seymour, Dan Lovallo, Kai Riemer, Alan R. Dennis and Lingyao (Ivy) Yuan All companies want to give their customers richer and more engaging ...

Jeffrey Goldberg and David Ignatius discuss America’s unique role in the post-World War II international order and Trump’s revolutionary approach to global leadership. May. 29, 2026 9:02 p.m. EDT Clip ...